Source: Signal Bay Inc.
Bend, OR, Sept. 07, 2017 (GLOBE NEWSWIRE) -- EVIO, Inc. (OTCQB: SGBYD) a leading provider of cannabis testing and advisory services announced today that its cannabis testing division EVIO Labs has entered into an agreement to license its brand and cannabis technology in Colorado. Phytatech CO, LLC which has been a licensed testing company since 2014, will now operate under the EVIO Labs brand.
EVIO CEO Mr. William Waldrop stated, "As we continue our mission to become the industry’s largest cannabis testing company, with operations in California, Oregon, Massachusetts, and Florida, EVIO is honored to now offer its accredited testing services to Colorado. The State of Colorado has continued to be an advocate and leader in the cannabis industry, being the first state to offer retail cannabis products, and the first to develop and enforce testing requirements.”
Phytatech CO, LLC was founded in 2014, and has been an industry leader in Colorado as both a licensed medical and retail (adult use) testing provider, servicing licensed cultivators and manufacturers of infused products (“MIPs”).
Phytatech founder Robert Howland commented, “Since the beginning we have had the resources to build a strong foundation. As the industry continues to mature we felt it important to engage a company such as EVIO Labs who is committed to improving the standards within the industry and provide us the resources to broaden our reach to the entire cannabis community. From an operational perspective in the short term, this will have little change to our existing clients. Moreover, in partnership with EVIO we seek to expand our overall service offerings to help our clients improve the quality of their products to meet the continued growing demand of the industry.”
EVIO, Inc. is a life science company that provides accredited analytical testing services and scientific research to the regulated cannabis industry. The Company’s EVIO Labs division provides state-mandated ancillary services that don’t directly support the supply chain, but are in place to ensure the safety and quality of the nation's cannabis supply. Learn more at www.eviolabs.com. The company can be reached directly @ 1-888-544-EVIO.
Company can be reached directly @ 1-888-544-EVIO.
Safe Harbor Statement
Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or www.eviolabs.com
Investor Relations: firstname.lastname@example.org
Retrieved from "http://globenewswire.com/news-release/2017/09/07/1114179/0/en/EVIO-Labs-Executes-Cannabis-Testing-License-Agreement-in-Colorado.html"